The rising challenge of non-AIDS-defining cancers in HIV-infected patients

John F. Deeken, Angelique Tjen-A-Looi, Michelle A. Rudek, Catherine Okuliar, Mary Young, Richard F. Little, Bruce J. Dezube

Research output: Contribution to journalArticlepeer-review

Abstract

Since the advent of HAART, patients with HIV infection have seen a significant improvement in their morbidity, mortality, and life expectancy. The incidence of AIDS-defining illnesses, including AIDS-defining malignancies, has been on the decline. However, deaths due to non-AIDS-defining illnesses have been on the rise. These so-called non-AIDS-defining cancers (NADCs) include cancers of the lung, liver, kidney, anus, head and neck, and skin, as well as Hodgkin's lymphoma. It is poorly understood why this higher rate of NADCs is occurring. The key challenge facing oncologists is how to administer chemotherapy effectively and safely to patients on antiretroviral therapy. The challenge to clinicians caring for HIV-infected patients is to develop and implement effective means to screen, treat, and prevent NADCs in the future. This review presents data on the epidemiology and etiology of NADCs, as well as ongoing research into this evolving aspect of the HIV epidemic.

Original languageEnglish (US)
Pages (from-to)1228-1235
Number of pages8
JournalClinical Infectious Diseases
Volume55
Issue number9
DOIs
StatePublished - Nov 1 2012

ASJC Scopus subject areas

  • Microbiology (medical)
  • Infectious Diseases

Fingerprint Dive into the research topics of 'The rising challenge of non-AIDS-defining cancers in HIV-infected patients'. Together they form a unique fingerprint.

Cite this